SpyGlass Pharma SGP
NASDAQ SGP
$34.97 +0.79 (+2.31%)
At close: Nov 11, 2026 · 4:00 PM EST

SpyGlass Pharma (SGP) Other Accumulated Expenses (2024 - 2026)

Updated

SpyGlass Pharma (SGP) posted Other Accumulated Expenses of $3.56 million for Q2 2026.

Analysis

SpyGlass Pharma (SGP) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, SpyGlass Pharma's Other Accumulated Expenses came in at $3.71 million, up 451.5% from FY2024.

  • In prior years, SpyGlass Pharma's Other Accumulated Expenses was $672,000 in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Other Accumulated Expenses since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 SpyGlass Pharma 1.14 Bn 534.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.56 Mn
Mar 31, 2026 2.27 Mn
Dec 31, 2025 3.71 Mn
Dec 31, 2024 672,000.00
API Access

SpyGlass Pharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SGP&period=max&api_key=YOUR_API_KEY